3BBLACKBIO · 3B Blackbio Dx Limited · Financials
Market Cap
11.51B INR
Shares
8.58M
Volume · Nov 13
22.06K
Avg daily vol (3M)
19.49K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.42B
+47.1%
FY2026
Net Income
585.86M
+22.9%
FY2026
Operating Cash Flow
524.76M
+21%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 1.68B | 1.42B | 964.69M |
| INR | 70.19M | 51.26M | 10.86M |
| INR | 3.53M | 2.37M | 1.09M |
| INR | 790.02M | 769.7M | 639.98M |
| INR | 197.53M | 170.4M | 163.07M |
| INR | 586.12M | 585.86M | 476.52M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 59.89M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.